SCHEMBL3498926

SCHEMBL3498926

CN(C)c1ccc(N=Nc2ccccc2)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ TSHR P16473 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ KMT2A Q03164 8/20 0.51
▸ NPC1 O15118 6/20 0.51
▸ RAB9A P51151 6/20 0.51
▸ MEN1 O00255 7/20 0.45
▸ CASP3 P42574 2/20 0.45
▸ SENP8 Q96LD8 2/20 0.45
▸ SENP7 Q9BQF6 2/20 0.45
▸ SENP6 Q9GZR1 2/20 0.45
▸ NSD2 O96028 1/20 0.45
▸ ALPL P05186 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ ALPG P10696 1/20 0.40
▸ MAPT P10636 5/20 0.39
▸ PKM P14618 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3498925 1.00 TDP1 (0.53) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL3341207 0.80 TDP1 (0.55) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL3341211 0.80 TDP1 (0.55) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL28543327 0.79 TDP1 (0.53) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL28543326 0.79 TDP1 (0.53) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL3501392 0.78 TDP1 (0.49) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL3501395 0.78 TDP1 (0.49) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL13829528 0.76 MAPK1 (0.47) TDP1MAPK1ALDH1A1TSHRHSD17B10
SCHEMBL27598721 0.72 MEN1 (0.55) TDP1MAPK1ALDH1A1HSD17B10KMT2A
Azobenzene SCHEMBL1405620 0.71 ALDH1A1 (0.75) TDP1MAPK1ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 — — US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 — — US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 — — US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 — — EP disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 — — US disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 — — WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 — — WO disclosed
Send feedback